The largest database of trusted experimental protocols

N methyl nitrosurea mnu

Manufactured by Merck Group
Sourced in United States

N-methyl-Nitrosurea (MNU) is a chemical compound used in laboratory settings. It is a colorless crystalline solid. MNU is commonly employed as a reagent in various scientific experiments and research applications.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using n methyl nitrosurea mnu

1

In-situ Bladder Cancer Rat Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
To further study the in vivo antitumor activity of PTK7-GEMs, we created a rat model of in-situ bladder cancer. Ether inhalation was used to anesthetize female SD rats, followed by infusion of their bladders with 0.2 ml of 10 mg mL− 1 N-methyl-Nitrosurea (MNU; Sigma) using a 22-gauge angiocatheter once every two weeks, five times. Postcatheterization, spontaneous micturition was avoided by keeping the rats anesthetized for approximately 45 min. After the successful induction of tumors (about 16 w), rats (n = 60) were placed in six groups, each comprising ten rats. After anesthesia, the rats’ bladders were instilled with PBS, PTK7, LIB, GEM, LIB-GEMs, or PTK7-GEMs (with the equivalent GEM concentration of 5 mg kg− 1). Spontaneous micturition was avoided by keeping the rats anesthetized for approximately 45 min. Treatments were given once each week for 5 w. The rats were subjected to human sacrifice at 2 days after the last dose. We dissected out the rats’ bladders, which were weighed, 4% paraformaldehyde-fixed for 24 h, paraffin-embedded, and subjected to histopathological examination. At the bladder midpoint, we cut transverse sections, followed by staining with H&E.
+ Open protocol
+ Expand
2

Bladder Cancer Tumor Induction and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the antitumor activity of SCNTs/si-circPRMT5 in vivo, an in situ model of bladder cancer was constructed. Ether inhalation was used to anesthetize female SD rats, whose bladders were then infused using 0.2 ml N-methyl-Nitrosurea (MNU) (10 mg/mL; Sigma, St. Louis, MO, USA,) employing a 22-gage angiocatheter once every 14 d for five times. For the avoidance of spontaneous micturition, the catheterized rats were kept under anesthesia for about 45 min [25 (link), 26 (link)].
After the successful induction of tumors, 40 rats were divided into 4 groups comprising 10 rats per group. The rats were anesthetized and their bladders were instilled with 500 μL of SCNTs/si-circPRMT5, si-circPRMT5 only, an equivalent dose of free SCNTs, or PBS. For the avoidance of spontaneous micturition, the catheterized rats were kept under anesthesia for about 45 min. These treatments were then delivered once weekly for 5 weeks. At 2 days after termination of therapy, the rats were sacrificed humanely, their bladders were removed, weighed, fixed for 1 d in 4% paraformaldehyde, paraffin-embedded, and examined histopathologically. Transverse sections cut from the midportion of the bladder were subjected to hematoxylin and eosin (H&E) staining.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!